|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeng H, Zheng R, Zhang S, Zuo T, Xia C,
Zou X and Chen W: Esophageal cancer statistics in China, 2011:
Estimates based on 177 cancer registries. Thorac Cancer. 7:232–237.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yao J, Shen X, Li H, Xu J, Shao S, Huang
JX and Lin M: LncRNA- ECM is overexpressed in esophageal squamous
cell carcinoma and promotes tumor metastasis. Oncol Lett.
16:3935–3942. 2018.PubMed/NCBI
|
|
4
|
Kayani B, Zacharakis E, Ahmed K and Hanna
GB: Lymph node metastases and prognosis in oesophageal carcinoma -
a systematic review. Eur J Surg Oncol. 37:747–753. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bai Y, Lin H, Fang Z, Luo Q, Fang Y, Su Y,
Hu Q, Duan H, Chen F and Zhang ZY: Plasma microRNA-19a as a
potential biomarker for esophageal squamous cell carcinoma
diagnosis and prognosis. Biomarkers Med. 11:431–441. 2017.
View Article : Google Scholar
|
|
6
|
Wu SG, Zhang WW, He ZY, Sun JY, Chen YX
and Guo L: Sites of metastasis and overall survival in esophageal
cancer: A population-based study. Cancer Manag Res. 9:781–788.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kato H, Fukuchi M, Miyazaki T, Nakajima M,
Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Manda R, et al:
Classification of recurrent esophageal cancer after radical
esophagectomy with two- or three-field lymphadenectomy. Anticancer
Res. 25:3461–3467. 2005.PubMed/NCBI
|
|
8
|
Doki Y, Ishikawa O, Takachi K, Miyashiro
I, Sasaki Y, Ohigashi H, Murata K, Yamada T, Noura S, Eguchi H, et
al: Association of the primary tumor location with the site of
tumor recurrence after curative resection of thoracic esophageal
carcinoma. World J Surg. 29:700–707. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bao Y, Liu S, Zhou Q, Cai P, Anfossi S, Li
Q, Hu Y, Liu M, Fu J, Rong T, et al: Three-dimensional conformal
radiotherapy with concurrent chemotherapy for postoperative
recurrence of esophageal squamous cell carcinoma: Clinical efficacy
and failure pattern. Radiat Oncol. 8:2412013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsu PK, Wang BY, Huang CS, Wu YC and Hsu
WH: Prognostic factors for post-recurrence survival in esophageal
squamous cell carcinoma patients with recurrence after resection. J
Gastrointest Surg. 15:558–565. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji K, Zhao L, Yang C, Meng M and Wang P:
Three-dimensional conformal radiation for esophageal squamous cell
carcinoma with involved-field irradiation may deliver considerable
doses of incidental nodal irradiation. Radiat Oncol. 7:2002012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta T, Agarwal J, Jain S, Phurailatpam
R, Kannan S, Ghosh-Laskar S, Murthy V, Budrukkar A, Dinshaw K,
Prabhash K, et al: Three-dimensional conformal radiotherapy
(3D-CRT) versus intensity modulated radiation therapy (IMRT) in
squamous cell carcinoma of the head and neck: A randomized
controlled trial. Radiother Oncol. 104:343–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang W, Liu X, Xiao Z, Wang L, Zhang H,
Chen D, Zhou Z, Feng Q, Hui Z, Liang J, et al: Efficacy of
intensity-modulated radiotherapy for resected thoracic esophageal
squamous cell carcinoma. Thorac Cancer. 6:597–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jager KJ, van Dijk PC, Zoccali C and
Dekker FW: The analysis of survival data: The Kaplan-Meier method.
Kidney Int. 74:560–565. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ni A and Cai J: Tuning parameter selection
in Cox proportional hazards model with a diverging number of
parameters. Scand Stat Theory Appl. 45:557–570. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dresner SM and Griffin SM: Pattern of
recurrence following radical oesophagectomy with two-field
lymphadenectomy. Br J Surg. 87:1426–1433. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Y, Chen Q, Yu X, Zhou X, Zheng X and
Mao W: Factors influencing the risk of recurrence in patients with
esophageal carcinoma treated with surgery: A single institution
analysis consisting of 1002 cases. Oncol Lett. 5:185–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakamura T, Hayashi K, Ota M, Eguchi R,
Ide H, Takasaki K and Mitsuhashi N: Salvage esophagectomy after
definitive chemotherapy and radiotherapy for advanced esophageal
cancer. Am J Surg. 188:261–266. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nemoto K, Ariga H, Kakuto Y, Matsushita H,
Takeda K, Takahashi C, Takai Y, Yamada S and Hosoi Y: Radiation
therapy for loco-regionally recurrent esophageal cancer after
surgery. Radiother Oncol. 61:165–168. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kawamoto T, Nihei K, Sasai K and Karasawa
K: Clinical outcomes and prognostic factors of chemoradiotherapy
for postoperative lymph node recurrence of esophageal cancer. Jpn J
Clin Oncol. 48:259–264. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Q, Cai XW, Wu B, Zhu ZF, Chen HQ and
Fu XL: Patterns of failure after radical surgery among patients
with thoracic esophageal squamous cell carcinoma: Implications for
the clinical target volume design of postoperative radiotherapy.
PLoS One. 9:e972252014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma DY, Tan BX, Liu M, Li XF, Zhou YQ and
Lu Y: Concurrent three-dimensional conformal radiotherapy and
chemotherapy for postoperative recurrence of mediastinal lymph node
metastases in patients with esophageal squamous cell carcinoma: A
phase 2 single-institution study. Radiat Oncol. 9:282014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jingu K, Matsushita H, Takeda K, Umezawa
R, Takahashi C, Sugawara T, Kubozono M, Abe K, Tanabe T, Shirata Y,
et al: Long-term results of radiotherapy combined with nedaplatin
and 5-fluorouracil for postoperative loco-regional recurrent
esophageal cancer: Update on a phase II study. BMC Cancer.
12:5422012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miyata H, Yamasaki M, Kurokawa Y,
Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, Mori M and Doki Y:
Survival factors in patients with recurrence after curative
resection of esophageal squamous cell carcinomas. Ann Surg Oncol.
18:3353–3361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen XL, Chen TW, Fang ZJ, Zhang XM, Li
ZL, Li H, Tang HJ, Zhou L, Wang D and Zhang Z: Patterns of lymph
node recurrence after radical surgery impacting on survival of
patients with pT1-3N0M0 thoracic esophageal squamous cell
carcinoma. J Korean Med Sci. 29:217–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Y, Chen S-W, Fan C-C, Ting L-L, Kuo
C-C and Chiou J-F: Clinical parameters for predicting
radiation-induced liver disease after intrahepatic reirradiation
for hepatocellular carcinoma. Radiat Oncol. 11:892016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Basaki K, Abe Y, Aoki M, Kondo H, Hatayama
Y and Nakaji S: Prognostic factors for survival in stage III
non-small-cell lung cancer treated with definitive radiation
therapy: Impact of tumor volume. Int J Radiat Oncol Biol Phys.
64:449–454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu D, Ma T, Niu Z, Zheng J, Han A, Zhao S
and Yu J: Prognostic significance of metabolic parameters measured
by (18)F-fluorodeoxyglucose positron emission tomography/computed
tomography in patients with small cell lung cancer. Lung Cancer.
73:332–337. 2011. View Article : Google Scholar : PubMed/NCBI
|
